Schnell Biopharmaceuticals IncA003060:KSC

507.00
27.00 / 5.63%
2.40m
17.09%
--
Close in KRWToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Sep 01 2014 16:00 BST.

Summary

On Tuesday, Schnell Biopharmaceuticals Inc (A003060:KSC) closed at 507.00, 33.77% above the 52 week low of 379.00 set on Jul 10, 2014.

52-week range
Today
379.00
Jul 10 2014
650.00
Oct 16 2013
Markit short selling activity
Low
Medium
High
Open481.00
Day high511.00
Day low481.00
Bid505.00
Offer507.00
Previous close480.00
Average volume2.47m
Shares outstanding137.08m
Free float115.20m
P/E (TTM)--
Market cap65.80bn KRW
EPS (TTM)-130.2128 KRW
Data delayed at least 20 minutes, as of Sep 01 2014 16:00 BST.

No new headlines available at this time

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Schnell Biopharmaceuticals Inc+5.63%+12.42%+13.17%+17.09%-66.78%
KOREA SE KOSPI IDX-0.80%-1.04%+4.99%+6.59%+27.18%
Data delayed at least 20 minutes, as of Sep 01 2014 16:00 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.